Events



You Are Here: Event > Understanding the Regulatory Requirements for the Over the Counter

Understanding the Regulatory Requirements for the Over the Counter


Wednesday
01.00 PM 
 
10777 Westheimer Suite 1100, Houston, Texas, USA,
Houston Texas 77042



Report Abuse

DESCRIPTION

The US FDA?s Center for Drug Evaluation and Research (CDER) is responsible for reviewing and approving both prescription and nonprescription or over-the-counter (OTC) drugs.
To introduce OTC (nonprescription) drug products into the U.S., it is important to accurately understand regulatory requirements applicable for the OTC products including regulatory pathways.
This webinar is intended to help you better understand how OTC nonprescription drugs are developed and brought into the US market.
The speaker will walk you through the regulatory requirements applicable to bring OTC drugs to the market.

Areas To Be Covered in this Seminar:

Laws and Regulations Governing OTC Drugs
Definitions
Key Considerations for OTC Drug Developments
Regulatory Pathways for OTC Drugs
Regulatory Requirements
FDA Review and Regulatory action
OTC Monographs
Critical Considerations
Understanding FDA and FTC Jurisdictions
Recent FDA Approvals of OTC Drugs
PASS-IT Recommendations

Who will benefit:

CEOs
VPs
Compliance Officers
Attorneys
Regulatory Affairs
Clinical Affairs
Quality Assurance
R&D
Consultants
Contractors/Subcontractors
Anyone Interested in the FDA Drug Review and Approval Processes

Webinar includes:

Q/A Session with the Expert to ask your question
PDF print only copy of PowerPoint slides
60 Minutes Live Presentation
Certificate of attendance
For?Registration?:??http://c2gowebinars.com/product/?topic=otc-drugs

Note:?Use?coupon?code????and?get?15% off?on?registration.
compliance2go
Phone: 8777824696
  8777824696
Email: subscribe (at) compliance2go.com
Report Abuse
 
Want to manage/update/remove your Listings?
Please enter your email or user-id
List your Event

Similar Events

Houston: Current Regulatory and Compliance Trends in the Area of Consent Decree
DESCRIPTION Topic Background: Many Years Ago Schering Plough underwent the first Consent Decree. Since, then many years elapsed and the term Consent Decree was foreign to many employees and employers and to Industry overall. Over the last Sev
Date Posted: 18-Feb-16


Houston: FDA vs Health Canada: Similarities and Differences by FDA Expert
DESCRIPTION Successful interaction with regulatory agencies can mean the difference between product license approvals and rejections; the difference between successful and unsuccessful PAI and routine inspections. Not all regulatory bodies are cr
Date Posted: 15-Apr-16


Houston: Preparing for Regulatory Audits by Carlson E. Patterson
DESCRIPTION This seminar will provide an overview of water systems used for pharmaceutical manufacturing. We will cover validation, monitoring, and analyzing data results. What data collected means, how excursions should be handled, and what acti
Date Posted: 15-Apr-16


FL: Live Webinar New and Expected Guidances on Data Standards and Electron
Live Webinar New and Expected Guidances on Data Standards and Electronic Submissions for Drugs and Medical Products Description Each FDA center has different guidelines and processes to follow in order to have a successful submission for the re
Date Posted: 30-Apr-18


FL: Live Webinar New and Expected Guidances on Data Standards and Electron
Live Webinar New and Expected Guidances on Data Standards and Electronic Submissions for Drugs and Medical Products Description Each FDA center has different guidelines and processes to follow in order to have a successful submission for the re
Date Posted: 11-May-18


Houston: FDA Inspection Preparation and Management: Important Considerations
DESCRIPTION This webinar is intended to provide practical and actionable information and guidance on how to proactively prepare for a sustainable FDA inspection and to better manage FDA inspection processes including key points of consideration.
Date Posted: 18-Feb-16


Houston: Effective Regulatory Inspections
DESCRIPTION The purpose of the Regulatory inspection is an activity that should demonstrate that your company is operating according to the proper CFR requirements and maintaining a state of compliance. The key to a successful audit is being able
Date Posted: 18-Apr-16


Houston: US EU and Japan GMP Requirements: Practical ICH Area Differences
DESCRIPTION This 90 minute webinar will help you gain a detailed overview of ICH GMPs and the nuances and differences between requirements in the US, EU and Japan. It will help prepare you for regulatory inspections in these countries. Why Sho
Date Posted: 18-Apr-16


Houston: Implementing a Change Control Quality System Successfully
DESCRIPTION This course will help attendees understand the fundamental change control steps and processes. It will focus on change proposals, assessments, execution and final implementation. The importance of proper planning, critical thinking s
Date Posted: 15-Apr-16


FL: Live Webinar Construct and Manage the Technical File and Design Dossie
Live Webinar Construct and Manage the Technical File and Design Dossier Description This Webinar will provide a substantive overview and outline differences between the Technical File and Design Dossier for those device firms dealing with the glo
Date Posted: 30-Apr-18


FL: Live Webinar FDA’s Final Rule Regarding Device Establishment Registrat
Live Webinar FDA’s Final Rule Regarding Device Establishment Registration and Listing: Procedure on How to Register and List Description Device firms, establishments or facilities that are involved in the production and distribution of medica
Date Posted: 08-May-18


FL: Live Webinar FDA’s Final Rule Regarding Device Establishment Registrat
Live Webinar FDA’s Final Rule Regarding Device Establishment Registration and Listing: Procedure on How to Register and List Description Device firms, establishments or facilities that are involved in the production and distribution of me
Date Posted: 27-Apr-18


Houston: FDA?s New Endotoxin Test Guidance for Human Parenteral Drugs, Biologic
DESCRIPTION Topic Background: FDA current thinking regarding Endotoxin testing has changed. Industry needs to adopt this new thinking in order to prevent observations, which lead to further scrutiny by the agency. Description: The curren
Date Posted: 15-Apr-16


Houston: Auditing the Risk Management File - By Dan O Leary
DESCRIPTION Medical device manufacturers must implement risk management systems for their devices. This can be a complicated system requiring a lot of work and multiple resources. If it is not correct, the regulatory authorities may require correc
Date Posted: 02-Feb-16


Houston: Introduction to Risk Management: Medical Devices
DESCRIPTION This webinar will cover Risk Management per ISO 14971 throughout the product lifecycle. Risk Management is an important process to methodically and effectively identifying and mitigating risks in the product design and manufacturing p
Date Posted: 18-Apr-16


Map locations are shown as per geocoding services and they depeneds on the accuracy of the address. If address is wrong it may show wrong map. If you put a listing which shows wrong map, please remove the listing and create a new one with correct address details.

Please note: The information on this site is submitted by users. CanadianDesi never checks accuracy of the information. Please use this information at your risk. If you have any question or concern regarding this listing, or you know that the above information is not accurate, please Contact Us. Thanks.
Please note: The information on this site is submitted by users. CanadianDesi never checks accuracy of the information. Please use this information at your risk. If you have any question or concern regarding this listing, or you know that the above information is not accurate, please Contact Us. Thanks. 


Share:
















Advertise Contact Us Privacy Policy and Terms of Usage FAQ
Canadian Desi
© 2001 Marg eSolutions


Site designed, developed and maintained by Marg eSolutions Inc.